Developing an institutional cancer biorepository for personalized medicine

Area of Science:

• Biomedical research infrastructure
• Cancer research
• Personalized medicine

Background:

• Human biospecimens and associated clinical information are essential for scientific discovery.
• Biorepositories collect, process, store, and distribute biospecimens for research.
• Advancements in genomics enable personalized medicine approaches.

Purpose of the Study:

• To review the development of an institutional cancer biorepository.
• To highlight the importance of biorepositories for clinical research and personalized medicine.
• To outline key requirements for successful biorepository management.

Main Methods:

• Review of existing literature and best practices in biorepository development.
• Emphasis on standardization, quality control, and information technology.
• Integration of genomic profiling for personalized medicine applications.

Main Results:

• Biorepositories serve as central hubs for high-quality, characterized biospecimens and data.
• Successful biorepository development requires specialized expertise and adherence to high operational standards.
• Cancer biorepositories are critical for advancing personalized medicine and clinical research.

Conclusions:

• Institutional cancer biorepositories are vital resources for advancing personalized medicine.
• Robust biorepository operations, including quality control and IT, are necessary for reliable research outcomes.
• Investment in funding, training, and certification is essential for biorepositories supporting personalized medicine.